SJ
Sheridan John F Chairman & CEO
C-suite M
US US · SEC (Form 4)
€165,392
▲ Purchases (1 ops.)
Explore the full record of transactions filed by Sheridan John F, Chairman & CEO. Insider active across 3 companies, notably Tandem Diabetes Care INC. In total, 15 filings have been recorded. Total volume traded: €165k. The latest transaction was filed on 16 June 2022 — Attribution. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations 15 total
08,400 shares 0
Common Stock
SEC:0000950103-22-010952:0 · 16 Jun 2022
0820 shares 0
Common Stock
SEC:0001438133-22-000153:0 · 27 May 2022
03,170 shares 0
Common Stock
SEC:0001438133-22-000077:0 · 16 May 2022
€165,392 2,500 shares @ €66.1569 0.011% mcap 80.7% of flow
Common Stock
SEC:0001438133-22-000069:0 · 9 May 2022
Ideal exit: 3 Feb 2023 (T+270) 0819 shares 0
Common Stock
SEC:0001438133-22-000027:0 · 28 Feb 2022
0820 shares 0
Common Stock
SEC:0001438133-21-000224 · 29 Nov 2021
0820 shares 0
Common Stock
SEC:0001438133-21-000224:0 · 29 Nov 2021
0820 shares 0
Common Stock
SEC:0001438133-21-000147 · 27 Aug 2021
0820 shares 0
Common Stock
SEC:0001438133-21-000147:0 · 27 Aug 2021
€6,970 746 shares @ €9.3437 0.0008% mcap 100.0% of flow
Common Stock
SEC:0001438133-21-000127 · 6 Aug 2021
€6,970 746 shares @ €9.3437 0.0005% mcap 3.4% of flow
Common Stock
SEC:0001438133-21-000127:0 · 6 Aug 2021
03,279 shares 0
Common Stock
SEC:0001438133-21-000068 · 27 May 2021
03,279 shares 0
Common Stock
SEC:0001438133-21-000068:0 · 27 May 2021
€16,255 296 shares @ €54.9154 100.0% of flow
Common Stock
SEC:0001438133-21-000062 · 17 May 2021
€16,255 296 shares @ €54.9154 0.0011% mcap 7.9% of flow
Common Stock
SEC:0001438133-21-000062:0 · 17 May 2021
About Sheridan John F John F Sheridan is an executive at TANDEM DIABETES CARE INC.